ASEP Medical Holdings Inc. (ASEP.CN)

0.1200 -0.0150 (-11.11%) At close: 03:33PM EDT

ASEP Medical Holdings Inc.

730 View Street
Unit 420
Victoria, BC V8W 3Y7
Canada
778-600-0509
https://asepmedical.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 7

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Robert E. W. Hancock FRSC, OC, Ph.D.	Founder, CEO & Executive Chairman	180k	N/A	1950
Ms. Jacqueline M. Tucker F.C.A., FCPA	Chief Financial Officer	90k	N/A	1956
Mr. Timothy W. Murphy	COO, Corporate Secretary & Director	120k	N/A	1972
Dr. Evan Haney	Chief Scientific Officer	73.5k	N/A	1984
Dr. Fadia Saad M.B.A., Ph.D.	Chief Business Development Officer	180k	N/A	1964

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis. It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and anti-fouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. ASEP Medical Holdings Inc. was incorporated in 2020 and is headquartered in Victoria, Canada.

Corporate Governance

ASEP Medical Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.